Article Text

other Versions

PDF
CASE REPORT
Development of an Intracranial Dural Arteriovenous Fistula after Venous Sinus Stenting for Idiopathic Intracranial Hypertension
  1. Thomas J Buell,
  2. Daniel M Raper,
  3. Dale Ding,
  4. Ching-Jen Chen,
  5. Kenneth C Liu
  1. Department of Neurosurgery, University of Virginia, Charlottesville, Virginia, USA
  1. Correspondence to Dr Thomas J Buell, Department of Neurosurgery, University of Virginia, Charlottesville; tjb4p{at}virginia.edu

Abstract

We report a case in which an intracranial dural arteriovenous fistula (DAVF) developed after endovascular treatment of a patient with idiopathic intracranial hypertension with venous sinus stenting (VSS). The pathogenesis may involve hemodynamic alterations secondary to increased poststenting venous sinus pressure, which may cause new arterial ingrowth into the fistulous sinus wall without capillary interposition. Despite administration of dual antiplatelet therapy, there may also be subclinical cortical vein thrombosis that contributed to DAVF formation. In addition to the aforementioned mechanisms, increased inflammation induced by VSS may upregulate vascular endothelial growth factor and platelet-derived growth factor expression and also promote DAVF pathogenesis. Since VSS has been used to obliterate DAVFs, DAVF formation after VSS may seem counterintuitive. Previous stents have generally been closed cell, stainless steel designs used to maximize radial compression of the fistulous sinus wall. In contrast, our patient’s stent was an open cell, self-expandable nitinol design (Protégé Everflex). Neurointerventionalists should be aware of this potential, although rare complication of DAVF formation after VSS.

  • angiography
  • complication
  • fistula
  • vein
  • stenosis

Statistics from Altmetric.com

Footnotes

  • Republished with permission from BMJ Case Reports Published 26 September 2017; doi: 10.1136/bcr-2017-013282

  • Contributors All authors made substantial contributions to the conception, data acquisition and analysis, interpretation or drafting of this research article. We approve this final version to be published.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.